Thomas Adams Ph.D., Director at Cardiff Oncology, Inc. (CRDF), bought 13,986 shares at $1.43 ($20K) on 2020-05-14, disclosed to the SEC on 2020-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IRIS | SELL | 2011-06-20 | $184K | — | Filing → |
| IRIS | SELL | 2007-09-20 | $330K | — | Filing → |